ArticleThe Prostate2018

Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC).

Edoardo Francini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.